Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bianca Rocca

Showing results (101-110 of 157) with videos related to

Pageof 16
Sort By:
Journal of Thrombosis and Thrombolysis|July 29, 2025
Management of cancer-associated venous thromboembolism: Perspectives on optimizing current therapeutics with a focus on factor XI inhibitionMassimiliano Camilli, Giovanni Occhipinti, Nicola Potere, et al.
Journal of Thrombosis and Haemostasis : JTH|July 19, 2024
Reversal of direct oral anticoagulants: guidance from the SSC of the ISTHJerrold H Levy, Joseph R Shaw, Lana A Castellucci, et al.
Research and Practice in Thrombosis and Haemostasis|December 19, 2024
Stability of the thromboxane B<sub>2</sub> biomarker of low-dose aspirin pharmacodynamics in human whole blood and in long-term stored serum samplesGiovanna Petrucci, Alessandro Rizzi, Simone Bellavia, et al.
Hemasphere|August 4, 2022
EHA Guidelines on Management of Antithrombotic Treatments in Thrombocytopenic Patients With CancerAnna Falanga, Avi Leader, Chiara Ambaglio, et al.
Thrombosis and Haemostasis|August 15, 2015
Abnormal megakaryopoiesis and platelet function in cyclooxygenase-2-deficient miceSilvia S Barbieri, Giovanna Petrucci, Eva Tarantino, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 20, 2025
Aspirin inhibition and recovery of cyclooxygenase activity and thromboxane biosynthesis in human megakaryocytes: a translational surrogate modelZahraa I Mallah, Giovanna Petrucci, Abeer J Ayoub, et al.
Blood|November 6, 2009
The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapyAlfredo Dragani, Silvia Pascale, Antonio Recchiuti, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|March 28, 2025
Key priorities for the implementation of the 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes in low-resource settingsNikolaus Marx, Katharina Schütt, Dirk Müller-Wieland, et al.
Diabetes|October 17, 2015
In Vivo Platelet Activation and Aspirin Responsiveness in Type 1 DiabetesFrancesco Zaccardi, Alessandro Rizzi, Giovanna Petrucci, et al.
Ecancermedicalscience|March 9, 2018
Aspirin: 120 years of innovation. A report from the 2017 Scientific Conference of the International Aspirin Foundation, 14 September 2017, Charité, BerlinJaqui Walker, Pippa Hutchison, Junbo Ge, et al.
Pageof 16

Showing results (101-110 of 157) with videos related to

Sort By:
Pageof 16
Journal of Thrombosis and Thrombolysis|July 29, 2025
Management of cancer-associated venous thromboembolism: Perspectives on optimizing current therapeutics with a focus on factor XI inhibitionMassimiliano Camilli, Giovanni Occhipinti, Nicola Potere, et al.
Journal of Thrombosis and Haemostasis : JTH|July 19, 2024
Reversal of direct oral anticoagulants: guidance from the SSC of the ISTHJerrold H Levy, Joseph R Shaw, Lana A Castellucci, et al.
Research and Practice in Thrombosis and Haemostasis|December 19, 2024
Stability of the thromboxane B<sub>2</sub> biomarker of low-dose aspirin pharmacodynamics in human whole blood and in long-term stored serum samplesGiovanna Petrucci, Alessandro Rizzi, Simone Bellavia, et al.
Hemasphere|August 4, 2022
EHA Guidelines on Management of Antithrombotic Treatments in Thrombocytopenic Patients With CancerAnna Falanga, Avi Leader, Chiara Ambaglio, et al.
Thrombosis and Haemostasis|August 15, 2015
Abnormal megakaryopoiesis and platelet function in cyclooxygenase-2-deficient miceSilvia S Barbieri, Giovanna Petrucci, Eva Tarantino, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 20, 2025
Aspirin inhibition and recovery of cyclooxygenase activity and thromboxane biosynthesis in human megakaryocytes: a translational surrogate modelZahraa I Mallah, Giovanna Petrucci, Abeer J Ayoub, et al.
Blood|November 6, 2009
The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapyAlfredo Dragani, Silvia Pascale, Antonio Recchiuti, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|March 28, 2025
Key priorities for the implementation of the 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes in low-resource settingsNikolaus Marx, Katharina Schütt, Dirk Müller-Wieland, et al.
Diabetes|October 17, 2015
In Vivo Platelet Activation and Aspirin Responsiveness in Type 1 DiabetesFrancesco Zaccardi, Alessandro Rizzi, Giovanna Petrucci, et al.
Ecancermedicalscience|March 9, 2018
Aspirin: 120 years of innovation. A report from the 2017 Scientific Conference of the International Aspirin Foundation, 14 September 2017, Charité, BerlinJaqui Walker, Pippa Hutchison, Junbo Ge, et al.
Pageof 16